MHK
De Cock Paul F reported 30,000 shares of Common Stock in MOHAWK INDUSTRIES INC as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 1, 2026. These were stock awards, not open-market purchases.
IBM
Pollack Martha E reported Grant or award in INTERNATIONAL BUSINESS MACHINES CORP: 268.00 units of Promised Fee Share (derivative), dated 2026-09-30. The full Form 4 contains 1 transaction entry.
CSTL
Juvenal Tobin W reported Sale in CASTLE BIOSCIENCES INC: 5543 units of Common Stock, dated 2026-09-29. The full Form 4 contains 2 transaction entries.
CMG
Rymer Adam T reported Tax/exercise withholding in CHIPOTLE MEXICAN GRILL INC: 3253 units of common stock, dated 2026-10-01. The full Form 4 contains 1 transaction entry.
ACT
Genworth Holdings, Inc. reported Sale in Enact Holdings, Inc.: 762894 units of Common Stock, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
RMD
Rider Michael J reported Grant or award in RESMED INC: 3230 units of ResMed Common Stock, dated 2026-08-14. The full Form 4 contains 1 transaction entry.
BMRN
Friberg Gregory R reported Tax/exercise withholding in BIOMARIN PHARMACEUTICAL INC: 4086 units of Common Stock, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
XYL
McShane Geri-Michelle reported 4,225 shares of Common Stock in Xylem Inc. as grants or awards dated 2026-10-01. The Form 4 was disclosed on Oct 1, 2026. These were stock awards, not open-market purchases.
JILL
Webb Mark W. reported Tax/exercise withholding in J.Jill, Inc.: 3513.4 units of Common Stock, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
CRVL
Combs Michael G reported 45 shares of Common Stock in CORVEL CORP as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 1, 2026. These were stock awards, not open-market purchases.
MXF
Saba Capital Management, L.P. reported Purchase in MEXICO FUND INC: 1238 units of Common Stock, dated 2026-09-30. The full Form 4 contains 1 transaction entry.
PKOH
VILSACK ROBERT D reported Sale in PARK OHIO HOLDINGS CORP: 196 units of Common Stock, dated 2026-09-29. The full Form 4 contains 30 transaction entries.
IZEA
BIERE PETER reported Exercise or conversion in IZEA Worldwide, Inc.: 200 units of Common Stock, dated 2026-09-30. The full Form 4 contains 5 transaction entries.
IZEA
Rua Daniel R reported 5,976 shares of Common Stock in IZEA Worldwide, Inc. as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 1, 2026. These were stock awards, not open-market purchases.
NFE
King Street Capital Management GP, L.L.C.; KING STREET CAPITAL MANAGEMENT, L.P.; HIGGINS BRIAN J reported Purchase in New Fortress Energy Inc.: 5000 units of Series A Mandatorily Convertible Preferred Stock (derivative), dated 2026-09-30. The full Form 4 contains 4 transaction entries.
IZEA
Boscolo Rodrigo reported 5,976 shares of Common Stock in IZEA Worldwide, Inc. as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 1, 2026. These were stock awards, not open-market purchases.
IZEA
GARDNER LINDSAY A reported 5,976 shares of Common Stock in IZEA Worldwide, Inc. as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 1, 2026. These were stock awards, not open-market purchases.
IZEA
Brady Brian W reported 5,976 shares of Common Stock in IZEA Worldwide, Inc. as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 1, 2026. These were stock awards, not open-market purchases.
IZEA
Bonchristiano Antonio reported 5,976 shares of Common Stock in IZEA Worldwide, Inc. as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 1, 2026. These were stock awards, not open-market purchases.
HCSG
WHALEN THOMAS GERARD reported 123 shares of Common Stock in HEALTHCARE SERVICES GROUP INC as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 1, 2026. These were stock awards, not open-market purchases.
ATYR
Yaras Brandon reported Grant or award in aTYR PHARMA INC: 410000 units of Employee Stock Option (right to buy) (derivative), dated 2026-10-01. The full Form 4 contains 1 transaction entry.
GRNT
Miller Matthew Reade reported 4,320 shares of Common Stock, par value $0.0001 per share in Granite Ridge Resources, Inc. as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 1, 2026. These were stock awards, not open-market purchases.
LEGN
Sanders Corazon (Corsee) D. reported Sale in Legend Biotech Corp: 27370 units of Ordinary Shares, dated 2026-09-29. The full Form 4 contains 1 transaction entry.
ELAN
Anand Kapila K reported Grant or award in Elanco Animal Health Inc: 642.0277 units of Deferred Stock Units (derivative), dated 2026-09-30. The full Form 4 contains 1 transaction entry.
AlphaYou
